Imaging Assay and Platform Advisory
We advise on imaging before the work begins. For drug discovery teams the advice covers the choice of microscope and modality, the design of an imaging assay for 2D, 3D, organoid or tissue work, and how to screen with the assay and validate it. For imaging and instrument companies it covers the drug discovery applications of a product, validation studies and technical content. The advice draws on experience of building microscopes and of running imaging assays at a CRO and at a pharma company.
Decision it supports. Which microscope, modality and assay design to use, and how to screen with the assay and validate it. For a company, which applications to support and how to substantiate a product claim for pharma users.
- For
-
Drug discovery teams that are planning or running imaging assays, and microscope and imaging system companies, reagent and tool companies, CROs and academic cores.
- Scope
-
The work is scoped for each engagement. For a drug discovery team it usually takes one or more of these forms:
- advice on the choice of microscope and imaging modality for a biological question
- the design of an imaging assay for 2D, 3D, organoid or tissue work, including the controls, the plate layout and, for cell-based assays, the probes and panels
- the design of a screen, and an assay validation plan with acceptance criteria
For an imaging or instrument company it usually takes one or more of these forms:
- advice on which drug discovery applications an instrument or reagent serves, and on how to support them
- a validation study design, with acceptance criteria that a pharma client will accept
- application notes and technical content written for a scientific reader
- a review of product claims against the benchmarks that customers read, and scientific support on customer calls
- a study protocol that the company's own team can run
- advice on which product or application to develop next
- Inputs
-
From a drug discovery team: the biological question, the samples, the instruments available, and any existing assay and data. From a company: the platform or assay, the claim that the company wants to support, the customer segment and the data that already exist.
- Deliverable
-
The deliverable is named in the proposal. It is usually a written recommendation, an imaging assay design, a validation plan or study design, or an application note.
- Timeline
-
Set in the proposal. The work is billed as a fixed fee, an hourly rate or a monthly retainer, whichever fits the work.
- Excluded
-
We do not run experiments, and for tissue work the staining assays remain with the client's lab. We accept nothing from any vendor in return for a recommendation. The no-commission rule.
Neuronal functionNeurodegeneration and proteinopathyNeuroimmunology and gliaImmunology and translational
Book a 30-minute call You answer a few short questions and choose a time. On the call we discuss your work and the decision you need to make.